{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T10:09:35Z","timestamp":1774346975794,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.sapharm.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:14:14Z","timestamp":1674702854000},"page":"758-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potentially inappropriate medications among elderly people with neurocognitive disorders \u2013 A nationwide register-based study using 3 different explicit criteria"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-8553","authenticated-orcid":false,"given":"Eva","family":"S\u00f6nnerstam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida","family":"Harlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.01.010_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6904-7-9","article-title":"Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005","volume":"7","author":"Patel","year":"2007","journal-title":"BMC Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sapharm.2023.01.010_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.healthpol.2017.05.007","article-title":"The ageing society and emergency hospital admissions","volume":"121","author":"Wittenberg","year":"2017","journal-title":"Health Pol"},{"issue":"2","key":"10.1016\/j.sapharm.2023.01.010_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm World Sci"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2023.01.010_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03319101","article-title":"Adverse drug events as a cause of hospitalization in older adults","volume":"35","author":"Salvi","year":"2012","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1445-5994.2001.00044.x","article-title":"Adverse drug events as a cause of hospital admission in the elderly","volume":"31","author":"Chan","year":"2001","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.sapharm.2023.01.010_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/imj.12455","article-title":"Adverse drug events are a major cause of acute medical admission","volume":"44","author":"McLachlan","year":"2014","journal-title":"Intern Med J"},{"issue":"9","key":"10.1016\/j.sapharm.2023.01.010_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00228-016-2084-3","article-title":"Drug-related hospital admissions among old people with dementia","volume":"72","author":"Gustafsson","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.sapharm.2023.01.010_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2023.01.010_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11096-017-0554-z","article-title":"Inappropriate anticholinergic drugs prescriptions in older patients: analysing a hospital database","volume":"40","author":"Ferret","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2023.01.010_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/014107680009300903","article-title":"Anticholinergic side-effects of drugs in elderly people","volume":"93","author":"Mintzer","year":"2000","journal-title":"J R Soc Med"},{"key":"10.1016\/j.sapharm.2023.01.010_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2050-6511-14-56","article-title":"Psychotropic drug use among people with dementia--a six-month follow-up study","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"issue":"11","key":"10.1016\/j.sapharm.2023.01.010_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.sapharm.2023.01.010_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apnu.2006.04.004","article-title":"Outcomes of antipsychotic drug use in community-dwelling elders with dementia","volume":"20","author":"Kolanowski","year":"2006","journal-title":"Arch Psychiatr Nurs"},{"issue":"10","key":"10.1016\/j.sapharm.2023.01.010_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00002512-200522100-00004","article-title":"Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events","volume":"22","author":"van Iersel","year":"2005","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.sapharm.2023.01.010_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"issue":"9582","key":"10.1016\/j.sapharm.2023.01.010_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2023.01.010_bib17","series-title":"Indikatorer F\u00f6r God L\u00e4kemedelsterapi Hos \u00c4ldre 2017 [Eng: Indicators of Good Drug Therapy in the Elderly 2017","year":"2017"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American geriatrics society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"The American Geriatric Society","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.sapharm.2023.01.010_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcp.12615","article-title":"Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates","volume":"80","author":"Morin","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.sapharm.2023.01.010_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00228-017-2218-2","article-title":"An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list","volume":"73","author":"S\u00f6nnerstam","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.01.010_bib21","series-title":"Indikatorer F\u00f6r Utv\u00e4rdering Av Kvaliteten I \u00c4ldres L\u00e4kemedelsterapi 2010. [Eng. Indicators for Evaluating the Quality O Folder People's Drug Therapy 2010","year":"2010"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1742-7843.2011.00682.x","article-title":"The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm","volume":"108","author":"Gustafsson","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.sapharm.2023.01.010_bib23","author":"Kloka"},{"issue":"9","key":"10.1016\/j.sapharm.2023.01.010_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pds.3827","article-title":"Association between drug-specific indicators of prescribing quality and quality of drug treatment: a validation study","volume":"24","author":"Wallerstedt","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2023.01.010_bib25","series-title":"Dementia","first-page":"915","author":"Ames","year":"2017"},{"issue":"21","key":"10.1016\/j.sapharm.2023.01.010_bib26","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations - the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.01.010_bib28","series-title":"Clinical Pharmacy and Therapeutics","first-page":"983","author":"Walker","year":"2012"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03602532.2017.1377223","article-title":"Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"4","key":"10.1016\/j.sapharm.2023.01.010_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11096-019-00847-x","article-title":"Assessment of potentially inappropriate medications using the EU (7)-PIM list and the Swedish quality indicators","volume":"41","author":"Wamil","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2023.01.010_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00228-017-2246-y","article-title":"Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol","volume":"73","author":"Mucalo","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.sapharm.2023.01.010_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jcpt.12494","article-title":"The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data","volume":"42","author":"Grina","year":"2017","journal-title":"J Clin Pharm Therapeut"},{"issue":"7","key":"10.1016\/j.sapharm.2023.01.010_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1345\/aph.1M147","article-title":"Sex differences in inappropriate drug use: a register-based study of over 600,000 older people","volume":"43","author":"Johnell","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.sapharm.2023.01.010_bib34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eurpsy.2015.05.001","article-title":"Gender differences in psychotropic use across Europe: results from a large cross-sectional, population-based study","volume":"30","author":"Boyd","year":"2015","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.sapharm.2023.01.010_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trci.2017.10.008","article-title":"Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis","volume":"4","author":"Ramsey","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"3","key":"10.1016\/j.sapharm.2023.01.010_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00228-021-03241-7","article-title":"Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries","volume":"78","author":"Kindstedt","year":"2022","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:30:27Z","timestamp":1761557427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112300030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S155174112300030X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.01.010","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentially inappropriate medications among elderly people with neurocognitive disorders \u2013 A nationwide register-based study using 3 different explicit criteria","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}